PGE2-EP2/EP4 signaling elicits immunosuppression by driving the mregDC-Treg axis in inflammatory tumor microenvironment-Reference-Cited by-同舟云学术

PGE2-EP2/EP4 signaling elicits immunosuppression by driving the mregDC-Treg axis in inflammatory tumor microenvironment

Published:2022-06 Issue:10 Volume:39 Page:110914
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Thumkeo Dean^ORCID,Punyawatthananukool Siwakorn^ORCID,Prasongtanakij Somsak^ORCID,Matsuura Ryuma,Arima Kentaro,Nie Huan,Yamamoto Rie^ORCID,Aoyama Naohiro,Hamaguchi Hisao,Sugahara Shingo,Takeda Shinobu,Charoensawan Varodom^ORCID,Tanaka Atsushi^ORCID,Sakaguchi Shimon,Narumiya Shuh

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference55 articles.

1. EP4 Antagonism by E7046 diminishes myeloid immunosuppression and synergizes with Treg-reducing IL-2-Diphtheria toxin fusion protein in restoring anti-tumor immunity;Albu;OncoImmunology,2017

2. Synthesis and structure- activity relationships of β- and α-piperidine sulfone hydoxamic acid matrix metalloproteinase inhibitors with oral antitumor efficacy;Becker;J. Med. Chem.,2005

3. Antagonistic inflammatory phenotypes dictate tumor fate and response to immune checkpoint blockade;Bonavita;Immunity,2020

4. Interferons alpha and beta in cancer: therapeutic opportunities from new insights;Borden;Nat. Rev. Drug Discov.,2019

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of PGE2 on TT cells viability and division;Prostaglandins & Other Lipid Mediators;2024-10

2. PGE2 synthesis and signaling in the liver physiology and pathophysiology: An update;Prostaglandins & Other Lipid Mediators;2024-10

3. MYC plus class IIa HDAC inhibition potentiates mitochondrial dysfunction in non-small cell lung cancer;2024-09-08

4. Persistent tailoring of MSC activation through genetic priming;Molecular Therapy - Methods & Clinical Development;2024-09

5. Reprogramming the immunosuppressive tumor microenvironment through nanomedicine: an immunometabolism perspective;eBioMedicine;2024-09